MGO One Seven’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

MGO One Seven’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-618	Closed	-$3K	–	1760
2018 Q4	$3K	Buy	+618	New	+$4.69K	﹤0.01%	1520

Other funds holding PRTK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

APCM

Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MGO One Seven's PRTK Position: Q1 2019 in Review

MGO One Seven sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q1 2019, closing a stake of 618 shares — an estimated $3K sold.

MGO One Seven first reported a position in PRTK in Q4 2018 and held it in 1 quarter. The position peaked at $3K in Q4 2018. 94 funds tracked by Wall St. Rank hold PRTK as of Q1 2019.

MGO One Seven reported no remaining Paratek Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
MGO One Seven sold 618 Paratek Pharmaceuticals, Inc. shares in Q1 2019, an estimated $3K.
MGO One Seven first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2018 and held it in 1 quarter.
MGO One Seven's Paratek Pharmaceuticals, Inc. position peaked at $3K in Q4 2018.
94 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q1 2019.

Based on MGO One Seven's 13F filing for Q1 2019, filed 9 Apr 2019.